• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Tuberculosis Drugs Market – 2019-2024” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Product Type and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Tuberculosis Drugs Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Tuberculosis Drugs Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Tuberculosis Drugs Market Size & Forecast:

Global Tuberculosis Drugs market witnessed a market value of USD XX Million in 2019 and is estimated to reach USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX% between 2019 and 2024. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:

- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Tuberculosis Drugs Market Segmentation:-
The research offers a comprehensive analysis of global Tuberculosis Drugs market with respect to following sub-markets:

Based on Therapy Type:
- First Line Therapy
- - - Isoniazid (INH)
- - - rifampicin (RIF)
- - - Ethambutol (EMB)
- - - Pyrazinamide (PZA)
- - - Streptomycin (SM).
- Second Line Therapy
- - - Fluoroquinolones
- - - Injectable antituberculosis drugs

Based on Disease Type:
- Active TB
- Latent TB

Based on Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

Global Tuberculosis Drugs Market: Competitive Landscape

The report also highlights the competitive landscape of the global Tuberculosis Drugs market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Technology development, research & development and other market activities).

The report includes profiles of leading companies in the global Tuberculosis Drugs market.

Some of the key players profiled include:

- Lupin ltd
- Johnson & Johnson Services, LLC
- Novartis AG
- Macleods Pharmaceuticals Ltd.
- Otsuka Pharmaceutical Co., Ltd
- Pfizer Inc.
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2015 to 2017 – Historical Year
- 2018 – Base Year
- 2019 – Estimated Year
- 2019 to 2024 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Tuberculosis Drugs Industry Report;

- What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface

1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process and Design
1.1.2.1. Secondary Research
1.1.2.2. Key Sources and Use of Primary Research
1.1.2.3. Market Size Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of the Study
1.5. Assumptions and Limitations for Market Estimation and Forecasting

2. Executive Summary

2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Tuberculosis Drugs Market Trends for 2019

3. Porter’s Five Force Analysis

3.1. Threat of Substitutes
3.2. Bargaining Power of Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New Entrants
3.5. Degree of Competition

4. Manufacturing Cost Structure Analysis

4.1. Raw Material and Suppliers
4.2. Industry Chain Structure of Tuberculosis Drugs Market
4.3. Manufacturing Process Analysis of Tuberculosis Drugs Market
4.4. Manufacturing Cost Structure Analysis of Tuberculosis Drugs Market

5. Manufacturing Plants Analysis of Tuberculosis Drugs Market

5.1. Capacity and Production
5.2. Global Tuberculosis Drugs Market Manufacturing Plants Distribution
5.3. Recent Development and Expansion Plans

6. Competitive Landscape

6.1. Global Tuberculosis Drugs Market 2018
6.2. Global Tuberculosis Drugs Market Value Share, By Company 2018
6.3. Global Tuberculosis Drugs Market Volume Share, By Company 2018

7. Market Dynamics

7.1. Growth Drivers & Barriers in Tuberculosis Drugs Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in Tuberculosis Drugs Market

8. Global Tuberculosis Drugs Market

8.1. Introduction
8.2. Key Trends & Growth Drivers
8.3. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

9. Global Tuberculosis Drugs Market Segmentation Analysis, By Therapy Type

9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Therapy Type
9.2.2. Market Attractiveness, By Therapy Type
9.3. First Line Therapy (Isoniazid, rifampicin, Ethambutol, Pyrazinamide, Streptomycin).
9.3.1. Key Trends & Growth Drivers
9.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Second Line Therapy (Fluoroquinolones & Injectable antituberculosis drugs)
9.4.1. Key Trends & Growth Drivers
9.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

10. Global Tuberculosis Drugs Market Segmentation Analysis, By Disease Type

10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Disease Type
10.2.2. Market Attractiveness, By Disease Type
10.3. Active TB
10.3.1. Key Trends & Growth Drivers
10.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Latent TB
10.4.1. Key Trends & Growth Drivers
10.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11. Global Tuberculosis Drugs Market Segmentation Analysis, By Distribution Channel

11.1. Introduction
11.2. Strategic Insights
11.2.1. BPS Analysis, By Distribution Channel
11.2.2. Market Attractiveness, By Distribution Channel
11.3. Hospital Pharmacies
11.3.1. Key Trends & Growth Drivers
11.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4. Retail Pharmacies
11.4.1. Key Trends & Growth Drivers
11.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5. Online Pharmacies
11.5.1. Key Trends & Growth Drivers
11.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12. Geographical Analysis

12.1. Introduction
12.2. North America Tuberculosis Drugs Market
12.2.1. Key Trends & Growth Drivers
12.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4. By Therapy Type
12.2.4.1. Introduction
12.2.4.2. Strategic Insights
12.2.4.2.1. BPS Analysis, By Therapy Type
12.2.4.2.2. Market Attractiveness, By Therapy Type
12.2.4.3. First Line Therapy (Isoniazid, rifampicin, Ethambutol, Pyrazinamide, Streptomycin).
12.2.4.3.1. Key Trends & Growth Drivers
12.2.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.4. Second Line Therapy (Fluoroquinolones & Injectable antituberculosis drugs)
12.2.4.4.1. Key Trends & Growth Drivers
12.2.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5. By Disease Type
12.2.5.1. Introduction
12.2.5.2. Strategic Insights
12.2.5.2.1. BPS Analysis, By Disease Type
12.2.5.2.2. Market Attractiveness, By Disease Type
12.2.5.3. Active TB
12.2.5.3.1. Key Trends & Growth Drivers
12.2.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.4. Latent TB
12.2.5.4.1. Key Trends & Growth Drivers
12.2.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6. By Distribution Channel
12.2.6.1. Introduction
12.2.6.2. Strategic Insights
12.2.6.2.1. BPS Analysis, By Distribution Channel
12.2.6.2.2. Market Attractiveness, By Distribution Channel
12.2.6.3. Hospital Pharmacies
12.2.6.3.1. Key Trends & Growth Drivers
12.2.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.4. Retail Pharmacies
12.2.6.4.1. Key Trends & Growth Drivers
12.2.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.5. Online Pharmacies
12.2.6.5.1. Key Trends & Growth Drivers
12.2.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7. By Country
12.2.7.1. Introduction
12.2.7.2. Strategic Insights
12.2.7.2.1. BPS Analysis, By Country
12.2.7.2.2. Market Attractiveness, By Country
12.2.7.3. U.S. Tuberculosis Drugs Market
12.2.7.3.1. Key Trends & Growth Drivers
12.2.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.4. Canada Tuberculosis Drugs Market
12.2.7.4.1. Key Trends & Growth Drivers
12.2.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.2.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.3. Europe Tuberculosis Drugs Market
12.3.1. Key Trends & Growth Drivers
12.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4. By Therapy Type
12.3.4.1. Introduction
12.3.4.2. Strategic Insights
12.3.4.2.1. BPS Analysis, By Therapy Type
12.3.4.2.2. Market Attractiveness, By Therapy Type
12.3.4.3. First Line Therapy (Isoniazid, rifampicin, Ethambutol, Pyrazinamide, Streptomycin).
12.3.4.3.1. Key Trends & Growth Drivers
12.3.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.4. Second Line Therapy (Fluoroquinolones & Injectable antituberculosis drugs)
12.3.4.4.1. Key Trends & Growth Drivers
12.3.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5. By Disease Type
12.3.5.1. Introduction
12.3.5.2. Strategic Insights
12.3.5.2.1. BPS Analysis, By Disease Type
12.3.5.2.2. Market Attractiveness, By Disease Type
12.3.5.3. Active TB
12.3.5.3.1. Key Trends & Growth Drivers
12.3.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.4. Latent TB
12.3.5.4.1. Key Trends & Growth Drivers
12.3.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6. By Distribution Channel
12.3.6.1. Introduction
12.3.6.2. Strategic Insights
12.3.6.2.1. BPS Analysis, By Distribution Channel
12.3.6.2.2. Market Attractiveness, By Distribution Channel
12.3.6.3. Hospital Pharmacies
12.3.6.3.1. Key Trends & Growth Drivers
12.3.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.4. Retail Pharmacies
12.3.6.4.1. Key Trends & Growth Drivers
12.3.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.5. Online Pharmacies
12.3.6.5.1. Key Trends & Growth Drivers
12.3.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7. By Country
12.3.7.1. Introduction
12.3.7.2. Strategic Insights
12.3.7.2.1. BPS Analysis, By Country
12.3.7.2.2. Market Attractiveness, By Country
12.3.7.3. Germany Tuberculosis Drugs Market
12.3.7.3.1. Key Trends & Growth Drivers
12.3.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.4. United Kingdom Tuberculosis Drugs Market
12.3.7.4.1. Key Trends & Growth Drivers
12.3.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.5. France Tuberculosis Drugs Market
12.3.7.5.1. Key Trends & Growth Drivers
12.3.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.6. Italy Tuberculosis Drugs Market
12.3.7.6.1. Key Trends & Growth Drivers
12.3.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.7. Russia Tuberculosis Drugs Market
12.3.7.7.1. Key Trends & Growth Drivers
12.3.7.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.8. Rest of Europe Tuberculosis Drugs Market
12.3.7.8.1. Key Trends & Growth Drivers
12.3.7.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.3.7.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.4. Asia Pacific Tuberculosis Drugs Market
12.4.1. Key Trends & Growth Drivers
12.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4. By Therapy Type
12.4.4.1. Introduction
12.4.4.2. Strategic Insights
12.4.4.2.1. BPS Analysis, By Therapy Type
12.4.4.2.2. Market Attractiveness, By Therapy Type
12.4.4.3. First Line Therapy (Isoniazid, rifampicin, Ethambutol, Pyrazinamide, Streptomycin).
12.4.4.3.1. Key Trends & Growth Drivers
12.4.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.4. Second Line Therapy (Fluoroquinolones & Injectable antituberculosis drugs)
12.4.4.4.1. Key Trends & Growth Drivers
12.4.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5. By Disease Type
12.4.5.1. Introduction
12.4.5.2. Strategic Insights
12.4.5.2.1. BPS Analysis, By Disease Type
12.4.5.2.2. Market Attractiveness, By Disease Type
12.4.5.3. Active TB
12.4.5.3.1. Key Trends & Growth Drivers
12.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.4. Latent TB
12.4.5.4.1. Key Trends & Growth Drivers
12.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6. By Distribution Channel
12.4.6.1. Introduction
12.4.6.2. Strategic Insights
12.4.6.2.1. BPS Analysis, By Distribution Channel
12.4.6.2.2. Market Attractiveness, By Distribution Channel
12.4.6.3. Hospital Pharmacies
12.4.6.3.1. Key Trends & Growth Drivers
12.4.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.4. Retail Pharmacies
12.4.6.4.1. Key Trends & Growth Drivers
12.4.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.5. Online Pharmacies
12.4.6.5.1. Key Trends & Growth Drivers
12.4.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7. By Country
12.4.7.1. Introduction
12.4.7.2. Strategic Insights
12.4.7.2.1. BPS Analysis, By Country
12.4.7.2.2. Market Attractiveness, By Country
12.4.7.3. China Tuberculosis Drugs Market
12.4.7.3.1. Key Trends & Growth Drivers
12.4.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.4. India Tuberculosis Drugs Market
12.4.7.4.1. Key Trends & Growth Drivers
12.4.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5. Japan Tuberculosis Drugs Market
12.4.7.5.1. Key Trends & Growth Drivers
12.4.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.5.3.1.1.
12.4.7.6. South Korea Tuberculosis Drugs Market
12.4.7.6.1. Key Trends & Growth Drivers
12.4.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.7. Indonesia Tuberculosis Drugs Market
12.4.7.7.1. Key Trends & Growth Drivers
12.4.7.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.8. Taiwan Tuberculosis Drugs Market
12.4.7.8.1. Key Trends & Growth Drivers
12.4.7.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.9. Australia Tuberculosis Drugs Market
12.4.7.9.1. Key Trends & Growth Drivers
12.4.7.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.10. New Zealand Tuberculosis Drugs Market
12.4.7.10.1. Key Trends & Growth Drivers
12.4.7.10.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.10.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.11. Rest of Asia Pacific Tuberculosis Drugs Market
12.4.7.11.1. Key Trends & Growth Drivers
12.4.7.11.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.4.7.11.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.5. Latin America Tuberculosis Drugs Market
12.5.1. Key Trends & Growth Drivers
12.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4. By Therapy Type
12.5.4.1. Introduction
12.5.4.2. Strategic Insights
12.5.4.2.1. BPS Analysis, By Therapy Type
12.5.4.2.2. Market Attractiveness, By Therapy Type
12.5.4.3. First Line Therapy (Isoniazid, rifampicin, Ethambutol, Pyrazinamide, Streptomycin).
12.5.4.3.1. Key Trends & Growth Drivers
12.5.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.4. Second Line Therapy (Fluoroquinolones & Injectable antituberculosis drugs)
12.5.4.4.1. Key Trends & Growth Drivers
12.5.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5. By Disease Type
12.5.5.1. Introduction
12.5.5.2. Strategic Insights
12.5.5.2.1. BPS Analysis, By Disease Type
12.5.5.2.2. Market Attractiveness, By Disease Type
12.5.5.3. Active TB
12.5.5.3.1. Key Trends & Growth Drivers
12.5.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.4. Latent TB
12.5.5.4.1. Key Trends & Growth Drivers
12.5.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6. By Distribution Channel
12.5.6.1. Introduction
12.5.6.2. Strategic Insights
12.5.6.2.1. BPS Analysis, By Distribution Channel
12.5.6.2.2. Market Attractiveness, By Distribution Channel
12.5.6.3. Hospital Pharmacies
12.5.6.3.1. Key Trends & Growth Drivers
12.5.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.4. Retail Pharmacies
12.5.6.4.1. Key Trends & Growth Drivers
12.5.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.5. Online Pharmacies
12.5.6.5.1. Key Trends & Growth Drivers
12.5.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7. By Country
12.5.7.1. Introduction
12.5.7.2. Strategic Insights
12.5.7.2.1. BPS Analysis, By Country
12.5.7.2.2. Market Attractiveness, By Country
12.5.7.3. Brazil Tuberculosis Drugs Market
12.5.7.3.1. Key Trends & Growth Drivers
12.5.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.4. Mexico Tuberculosis Drugs Market
12.5.7.4.1. Key Trends & Growth Drivers
12.5.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.5. Rest of Latin America Tuberculosis Drugs Market
12.5.7.5.1. Key Trends & Growth Drivers
12.5.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.5.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12.6. Middle East & Africa Tuberculosis Drugs Market
12.6.1. Key Trends & Growth Drivers
12.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4. By Therapy Type
12.6.4.1. Introduction
12.6.4.2. Strategic Insights
12.6.4.2.1. BPS Analysis, By Therapy Type
12.6.4.2.2. Market Attractiveness, By Therapy Type
12.6.4.3. First Line Therapy (Isoniazid, rifampicin, Ethambutol, Pyrazinamide, Streptomycin).
12.6.4.3.1. Key Trends & Growth Drivers
12.6.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.4. Second Line Therapy (Fluoroquinolones & Injectable antituberculosis drugs)
12.6.4.4.1. Key Trends & Growth Drivers
12.6.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5. By Disease Type
12.6.5.1. Introduction
12.6.5.2. Strategic Insights
12.6.5.2.1. BPS Analysis, By Disease Type
12.6.5.2.2. Market Attractiveness, By Disease Type
12.6.5.3. Active TB
12.6.5.3.1. Key Trends & Growth Drivers
12.6.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.4. Latent TB
12.6.5.4.1. Key Trends & Growth Drivers
12.6.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6. By Distribution Channel
12.6.6.1. Introduction
12.6.6.2. Strategic Insights
12.6.6.2.1. BPS Analysis, By Distribution Channel
12.6.6.2.2. Market Attractiveness, By Distribution Channel
12.6.6.3. Hospital Pharmacies
12.6.6.3.1. Key Trends & Growth Drivers
12.6.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.4. Retail Pharmacies
12.6.6.4.1. Key Trends & Growth Drivers
12.6.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.5. Online Pharmacies
12.6.6.5.1. Key Trends & Growth Drivers
12.6.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7. By Geography
12.6.7.1. Introduction
12.6.7.2. Strategic Insights
12.6.7.2.1. BPS Analysis, By Geography
12.6.7.2.2. Market Attractiveness, By Geography
12.6.7.3. GCC Tuberculosis Drugs Market
12.6.7.3.1. Key Trends & Growth Drivers
12.6.7.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.4. North Africa Tuberculosis Drugs Market
12.6.7.4.1. Key Trends & Growth Drivers
12.6.7.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.5. South Africa Tuberculosis Drugs Market
12.6.7.5.1. Key Trends & Growth Drivers
12.6.7.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.6. Rest of Middle East & Africa Tuberculosis Drugs Market
12.6.7.6.1. Key Trends & Growth Drivers
12.6.7.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
12.6.7.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

13. Company Profile
13.1. Market Share of Key Players in Tuberculosis Drugs Market
13.2. Tuberculosis Drugs Market Company Analysis
13.2.1. Lupin ltd
13.2.1.1. Company Overview
13.2.1.2. Product Offered
13.2.1.3. Business Strategy
13.2.1.4. Financials
13.2.1.5. SWOT Analysis
13.2.1.6. Market Share Analysis
13.2.1.7. Key Achievements & Developments
13.2.2. Johnson & Johnson Services, LLC
13.2.2.1. Company Overview
13.2.2.2. Product Offered
13.2.2.3. Business Strategy
13.2.2.4. Financials
13.2.2.5. SWOT Analysis
13.2.2.6. Market Share Analysis
13.2.2.7. Key Achievements & Developments
13.2.3. Novartis AG
13.2.3.1. Company Overview
13.2.3.2. Product Offered
13.2.3.3. Business Strategy
13.2.3.4. Financials
13.2.3.5. SWOT Analysis
13.2.3.6. Market Share Analysis
13.2.3.7. Key Achievements & Developments
13.2.4. Macleods Pharmaceuticals Ltd.
13.2.4.1. Company Overview
13.2.4.2. Product Offered
13.2.4.3. Business Strategy
13.2.4.4. Financials
13.2.4.5. SWOT Analysis
13.2.4.6. Market Share Analysis
13.2.4.7. Key Achievements & Developments
13.2.5. Otsuka Pharmaceutical Co., Ltd
13.2.5.1. Company Overview
13.2.5.2. Product Offered
13.2.5.3. Business Strategy
13.2.5.4. Financials
13.2.5.5. SWOT Analysis
13.2.5.6. Market Share Analysis
13.2.5.7. Key Achievements & Developments
13.2.6. Pfizer Inc.
13.2.6.1. Company Overview
13.2.6.2. Product Offered
13.2.6.3. Business Strategy
13.2.6.4. Financials
13.2.6.5. SWOT Analysis
13.2.6.6. Market Share Analysis
13.2.6.7. Key Achievements & Developments
13.2.7. Other Prominent Players

14. Disclaimer

Select License Type
  • Single User License $3750 USD
  • Multi-User License $4750 USD
  • Corporate User License $5750 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients